Flow-Synchronized Nasal Intermittent Positive Pressure Ventilation for Infants <32 Weeks' Gestation with Respiratory Distress Syndrome

Table 2

Neonatal outcomes in the two study groups.

	INSURE/NCPAP (n.31)	INSURE/SNIPPV (n.33)	𝑃 value
INSURE failure	11 (35.5)	2 (6.1)	0.004
Pneumothorax	1 (3.2)	0	0.484
Surfactant second dose	7 (22.6)	1 (3.0)	0.025
Caffeine high maintenance dose	9 (29.0)	3 (9.9)	0.041
PDA treated	8 (25.8)	2 (6.1)	0.041
Postnatal steroids	4 (12.9)	1 (3.0)	0.190
O2 dep. at 28 days	6 (19.3)	1 (3.0)	0.050
O2 dep. at 36 weeks PMA	4 (12.9)	0	0.050
Late onset sepsis	4 (12.9)	4 (12.1)	1.000
Feeding intolerance	3 (9.7)	4 (12.1)	1.000
NEC	1 (3.2)	0	0.484
IVH (1-2°)	2 (6.4)	2 (6.0)	1.000
IVH (3-4°)	1 (3.2)	1 (3.0)	1.000
PVL	0	0	1.000
ROP	0	1 (3.0)	1.000
Death	0	0	1.000

Values are given as number and (%).